Mitchell Sinkler & Starr’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Buy
5,150
+655
+15% +$61.7K 0.15% 119
2026
Q1
$531K Buy
4,495
+180
+4% +$22.3K 0.25% 91
2025
Q4
$543K Buy
4,315
+2,190
+103% +$286K 0.25% 86
2025
Q3
$311K Buy
2,125
+120
+6% +$18.1K 0.14% 128
2025
Q2
$313K Buy
2,005
+100
+5% +$15.9K 0.15% 122
2025
Q1
$314K Sell
1,905
-891
-32% -$148K 0.09% 131
2024
Q4
$456K Sell
2,796
-185
-6% -$33.1K 0.12% 108
2024
Q3
$582K Sell
2,981
-110
-4% -$20.3K 0.15% 97
2024
Q2
$554K Buy
3,091
+629
+26% +$105K 0.14% 95
2024
Q1
$417K Sell
2,462
-102
-4% -$19.1K 0.1% 120
2023
Q4
$506K Buy
2,564
+595
+30% +$105K 0.09% 129
2023
Q3
$343K Buy
1,969
+179
+10% +$32.5K 0.11% 94
2023
Q2
$308K Hold
1,790
0.09% 121
2023
Q1
$298K Buy
+1,790
New +$293K 0.09% 121

Other funds holding ZTS

Mitchell Sinkler & Starr's ZTS Position: Q2 2026 in Review

Mitchell Sinkler & Starr increased its Zoetis (ZTS) stake by 15% in Q2 2026, buying an estimated $61.7K and bringing the position to 5,150 shares worth $370K. The position accounts for 0.15% of the portfolio, ranked #119.

Mitchell Sinkler & Starr first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. The position peaked at $582K in Q3 2024. 385 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Mitchell Sinkler & Starr held 5,150 shares of Zoetis worth $370K as of Q2 2026.
  • Mitchell Sinkler & Starr bought 655 Zoetis shares in Q2 2026, an estimated $61.7K.
  • Zoetis made up 0.15% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #119 holding.
  • Mitchell Sinkler & Starr first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • Mitchell Sinkler & Starr's Zoetis position peaked at $582K in Q3 2024.
  • 385 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.